Valganciclovir thrice weekly for prophylaxis against cytomegalovirus reactivation during alemtuzumab therapy

Leukemia. 2009 Apr;23(4):800-1. doi: 10.1038/leu.2008.282. Epub 2008 Oct 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / administration & dosage*
  • Cytomegalovirus / drug effects*
  • Drug Evaluation
  • Ganciclovir / administration & dosage
  • Ganciclovir / analogs & derivatives*
  • Humans
  • Premedication
  • Valganciclovir
  • Virus Activation / drug effects

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Alemtuzumab
  • Valganciclovir
  • Ganciclovir